Hematological differences between patients with different subtypes of sickle cell disease on hydroxyurea treatment

OBJECTIVE: Sickle cell anemia and the interaction S/Beta thalassemia differ in hematological values due to microcytosis and hypochromia caused by the thalassemic mutation. The clinical benefit of long-term hydroxyurea treatment is undeniable in sickle cell disease with monitoring of the biological a...

Descripción completa

Detalles Bibliográficos
Autores principales: Neves, Fabia, Menezes Neto, Osvaldo Alves, Polis, Larissa Bueno, Bassi, Sarah Cristina, Brunetta, Denise Menezes, Silva-Pinto, Ana Cristina, Angulo, Ivan Lucena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545429/
https://www.ncbi.nlm.nih.gov/pubmed/23323066
http://dx.doi.org/10.5581/1516-8484.20120107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545429/
https://www.ncbi.nlm.nih.gov/pubmed/23323066
http://dx.doi.org/10.5581/1516-8484.20120107

Ejemplares similares